Feasibility Study: Early Experiences With a Cancer Center's Virtual Expert Medical Opinion Program
JCO Oncology Practice · 09.04.2026
DOI: 10.1200/op-25-00510 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCO Oncology Practice, online erschienen am 09.04.2026. Verfasst von Allison Lipitz-Snyderman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
PURPOSE Second opinion consultations are a promising strategy to identify errors in diagnosis and recommend optimal treatment. Yet, there are geographic barriers. By bringing high-level care to patients where they live, virtual second opinion programs might benefit populations without access to specialty cancer centers. We conducted a feasibility study that examined changes in treatment recommended through a national virtual second opinion program based at a comprehensive cancer center. METHODS Memorial Sloan Kettering Cancer Center (MSK)'s virtual second opinion program was developed via a national cancer employer benefits solution. Each review was conducted by an MSK subspecialist and supported by a digital platform. After conducting the second opinion, subspecialists answered a questionnaire regarding their perceptions of the expected impact of recommended treatment changes. Here, we report findings from December 2023 to November 2024. RESULTS There were 231 cases completed. There were 55% women, with a median age of 56 years. Patients resided across the United States, with 56% from the South. The most common cancer categories were breast, GI and mixed tumor (GMT), and prostate. Cases were reviewed by 76 unique subspecialists. Subspecialists perceived that they made a meaningful change in recommended treatment (expected to affect patient outcomes) in 75 cases (32%). Expected changes included better prognosis/survival (n = 49, 65%), improved short-term morbidity/quality of life/toxicity (n = 36, 48%), or improved long-term morbidity/quality of life/toxicity (n = 49, 65%). There was a higher percent of recommended changes for liquid compared with solid tumor cases (liquid: 15 of 31, 48%; solid: 60 of 200, 30%). CONCLUSION Findings are helpful for understanding the potential impact of a virtual second opinion program for patients with cancer and for developing strategies to reach underserved communities with geographic access barriers to high-quality cancer care from subspecialists.
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY.
- Department of Strategy Innovation and Technology Development, Memorial Sloan Kettering Cancer Center, New York, NY.
- Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
- Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
ORCID-Profile: Allison Lipitz-Snyderman, Susan Chimonas, Brendan Raftery, Lauren Klein Levine, Sergio Giralt, Tiffany Traina, Benjamin R Roman
Förderung
- NCI NIH HHS
Zitieren
APA
Lipitz-Snyderman, A., Chimonas, S., Raftery, B., Levine, L. K., Manship, C., Giralt, S., Traina, T., Sugarman, S., & Roman, B. R. (2026). Feasibility Study: Early Experiences With a Cancer Center's Virtual Expert Medical Opinion Program. JCO Oncology Practice. https://doi.org/10.1200/op-25-00510
Vancouver
Lipitz-Snyderman A, Chimonas S, Raftery B, Levine LK, Manship C, Giralt S, et al. Feasibility Study: Early Experiences With a Cancer Center's Virtual Expert Medical Opinion Program. JCO Oncology Practice. 2026. doi:10.1200/op-25-00510
BibTeX
@article{LipitzSnyderman2026,
author = {Lipitz-Snyderman, Allison and Chimonas, Susan and Raftery, Brendan and Levine, Lauren Klein and Manship, Cole and Giralt, Sergio and Traina, Tiffany and Sugarman, Steven and Roman, Benjamin R},
title = {Feasibility Study: Early Experiences With a Cancer Center's Virtual Expert Medical Opinion Program},
journal = {JCO Oncology Practice},
year = {2026},
doi = {10.1200/op-25-00510}
}
EUVIMED